Search
for
Sort by
Research 601–630 of 1000+
- Involvement of hair follicles in skin tumorigenesis, skin homeostasis and wound healing
- Molecular monitoring of short- and long-term transcriptional effects of hair growth stimulating agents
- Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
- Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention
- Aesthetic Rehabilitation Medicine: Enhancing Wellbeing beyond Functional Recovery
- Progress in Research and Prospects for Application of Precision Gene-Editing Technology Based on CRISPR–Cas9 in the Genetic Improvement of Sheep and Goats
- The Biology and Genomics of Human Hair Follicles: A Focus on Androgenetic Alopecia
- Understanding Type 3 Innate Lymphoid Cells and Crosstalk with the Microbiota: A Skin Connection
- Oral Combination Treatment of Gefitinib (IressaTM) and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line
- Isolation and HPLC Quantitative Determination of 5α-Reductase Inhibitors from Tectona grandis L.f. Leaf Extract
- Role of polymorphism of the androgen receptor gene andnon-random x chromosome inactivation in the pathogenesisof androgenic alopecia
- Rational Design and Synthesis of 4-((1<i>R</i>,2<i>R</i>)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a Novel, Nonsteroidal Androgen Receptor Antagonist Devoid of Phototoxicity for Dermatological Indications
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- Kevis P.F. – an adjunctive hair maintenance option
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Distinguishing histopathologic features of acantholytic dermatoses and the pattern of acantholytic hypergranulosis
- Thyroid receptor agonists for the treatment of androgenetic alopecia
- Comparison of High-Dose Corticosteroid Pulse Therapy and Combination Therapy Using Oral Cyclosporine with Low-Dose Corticosteroid in Severe Alopecia Areata
- Miniaturization of sebaceous glands: A novel histopathological finding in pemphigus vulgaris and pemphigus foliaceus of the scalp
- Long-term stability of frozen platelet-rich plasma under −80 °C storage condition
- The Mean Staple Length of Wool Fibre Is Associated with Variation in the Ovine Keratin-Associated Protein 21-2 Gene
- Panfolliculoma: Report of the Youngest Case and Literature Review of Its Histopathologic Variants
- Probing androgen receptor co-factor selectivity profiles: a chemical tool to determine cross-talk between androgen receptor and β-catenin in vivo
- Microarray Gene Expression Analysis of Lesional Skin in Canine Pemphigus Foliaceus
- use of dermoscope to differentiate Pityrosporum folliculitis and Acne vulgaris
- Pityrosporum folliculitis in immunocompromised populations: A systematic review
- Persistent pemphigus vulgaris and pemphigus foliaceus showing features of tufted hair folliculitis just on the scalp
- Electric Stimulation at 448 kHz Modulates Proliferation and Differentiation of Follicle Dermal Papilla Cells
- Beyond PRP : Recognizing the Evolving Generations of Platelet Concentrates in Androgenetic Alopecia Treatment—A Letter in Response to Zhong Et al
- 0475 High-dose UVA-1 therapy improves patient-reported outcomes and clinical scores in patients with sclerosing skin disease